Table 2 Healthcare characteristics of diabetes participants in Brazil and Mexico surveys
Countries | ||||||
|---|---|---|---|---|---|---|
Brazil n (%) | Mexico n (%) | Total n (%) | X2 | df | P* | |
Access to medical care | ||||||
No | 931 (25.6) | 267 (5.8) | 1198 (14.6) | 182.551 | 1 | < 0.0001 |
Yes | 2705 (74.3) | 4288 (94.1) | 6993 (85.3) | |||
Type of medical care | ||||||
Private | 768 (21.1) | 680 (14.9) | 1448 (17.6) | 184.233 | 3 | < 0.0001 |
Public | 1915 (52.6) | 3371 (74.0) | 5286 (64.5) | |||
Do not receive | 931 (25.6) | 267 (5.8) | 1198 (14.6) | |||
Other | 22 (0.6) | 237 (5.2) | 259 (3.1) | |||
Type of diabetes treatment | ||||||
None | 742 (20.4) | 600 (13.1) | 1306 (15.9) | 229.920 | 3 | < 0.0001 |
Insulin | 162 (4.4) | 339 (7.4) | 401 (4.8) | |||
Oral medications | 2253 (61.9) | 3397 (74.5) | 5650 (68.9) | |||
Both | 479 (13.1) | 290 (6.3) | 769 (9.3) | |||
Measurement of venous glucose | ||||||
No | 717 (19.7) | 2707 (59.4) | 3424 (41.8) | 1474.135 | 1 | < 0.0001 |
Yes | 2919 (80.2) | 1848 (40.5) | 4767 (58.2) | |||
Use of glucose strips (glucometer) | ||||||
No | 1631 (44.8) | 3238 (71.0) | 4869 (59.4) | 914.141 | 1 | < 0.0001 |
Yes | 2005 (55.1) | 1317 (28.9) | 3322 (40.6) | |||
HbA1C | ||||||
No | 1403 (38.5) | 3654 (80.2) | 5057 (61.7) | 3126.558 | 1 | < 0.0001 |
Yes | 2233 (61.4) | 901 (19.7) | 3134 (38.2) | |||
Urinalysis | ||||||
No | 1102 (30.3) | 2675 (58.7) | 3777 (46.2) | 1618.638 | 1 | < 0.0001 |
Yes | 2534 (69.6) | 1880 (41.3) | 4414 (53.8) | |||
Foot exam | ||||||
No | 1821 (50.0) | 3395 (74.6) | 5216 (63.7) | 1661.402 | 1 | < 0.0001 |
Yes | 1815 (49.9) | 1161 (25.4) | 2976 (36.3) | |||